Healthpeak Properties (NYSE: DOC) has recently received a number of price target changes and ratings updates:
- 8/13/2026 – Healthpeak Properties had its price target raised by Robert W. Baird from $21.00 to $24.00. They now have an “outperform” rating on the stock.
- 8/11/2026 – Healthpeak Properties had its price target raised by Citigroup Inc. from $20.00 to $22.00. They now have a “neutral” rating on the stock.
- 8/10/2026 – Healthpeak Properties had its price target raised by Royal Bank Of Canada from $21.00 to $24.00. They now have an “outperform” rating on the stock.
- 8/6/2026 – Healthpeak Properties had its price target raised by Cantor Fitzgerald from $20.00 to $23.00. They now have a “neutral” rating on the stock.
- 8/5/2026 – Healthpeak Properties had its “hold (c)” rating reaffirmed by Weiss Ratings.
- 7/15/2026 – Healthpeak Properties had its price target raised by Wells Fargo & Company from $20.00 to $22.00. They now have an “equal weight” rating on the stock.
- 7/8/2026 – Healthpeak Properties had its price target raised by UBS Group AG from $19.00 to $21.50. They now have a “neutral” rating on the stock.
- 7/7/2026 – Healthpeak Properties is now covered by Barclays PLC. They set an “equal weight” rating and a $23.00 price target on the stock.
- 7/6/2026 – Healthpeak Properties had its price target raised by Mizuho from $21.00 to $24.00. They now have an “outperform” rating on the stock.
- 6/24/2026 – Healthpeak Properties had its price target raised by JPMorgan Chase & Co. from $18.00 to $21.00. They now have a “neutral” rating on the stock.
Healthpeak Properties Announces Dividend
The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be given a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s payout ratio is 348.57%.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
See Also
- Five stocks we like better than Healthpeak Properties
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Healthpeak Properties Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties Inc and related companies with MarketBeat.com's FREE daily email newsletter.
